DIVIS LABORATORIES
Back to Cashflow Statement
|
DIVIS LABORATORIES Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-269 Cr | ₹-2,707 Cr | ₹-2,195 Cr | ₹75 Cr | ₹-83 Cr |
What is the latest Cash Flow from Investing Activities ratio of DIVIS LABORATORIES ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2024 | ₹-269 Cr |
Mar2023 | ₹-2,707 Cr |
Mar2022 | ₹-2,195 Cr |
Mar2021 | ₹75 Cr |
Mar2020 | ₹-83 Cr |
How is Cash Flow from Investing Activities of DIVIS LABORATORIES Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-269 Cr | Negative | |
Mar2023 | ₹-2,707 Cr | Negative | |
Mar2022 | ₹-2,195 Cr | Negative | |
Mar2021 | ₹75 Cr | Positive | |
Mar2020 | ₹-83 Cr | - |
Compare Cash Flow from Investing Activities of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹158,654.8 Cr | 3.5% | 0.9% | 66.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹426,518.0 Cr | -0.1% | -6.3% | 49.2% | Stock Analytics | |
CIPLA | ₹118,368.0 Cr | -2.6% | -3.8% | 19.2% | Stock Analytics | |
MANKIND PHARMA | ₹102,273.0 Cr | 0.9% | -3.4% | 37% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,671.4 Cr | -4.1% | -10.8% | 9.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,013.6 Cr | -2% | -6.1% | 49.9% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | 3.5% |
0.9% |
66.2% |
SENSEX | -1.9% |
-5% |
17.5% |
You may also like the below Video Courses